Phibro Animal Health (PAHC) Change in Account Payables (2013 - 2026)
Phibro Animal Health (PAHC) posted Change in Account Payables of -$5.6 million for Q2 2026, down 91.94% on a QoQ basis from -$2.9 million in Q1 2026, and down 315.62% year-over-year from $2.6 million in Q2 2025.
Analysis
Phibro Animal Health (PAHC) Change in Account Payables (2013 - 2026) Analysis & Trends
Phibro Animal Health has reported Change in Account Payables for 14 years, with the latest figure at -$5.6 million in Q2 2026.
- On a quarterly basis, Change in Account Payables fell 315.62% year-over-year to -$5.6 million in Q2 2026; TTM through Jun 2026 was -$12.5 million, a 127.36% decrease from a year earlier, with the FY2026 full-year figure at -$12.5 million, down 127.36% from the prior year.
- Change in Account Payables was -$5.6 million for Q2 2026 at Phibro Animal Health, down from -$2.9 million in the prior quarter.
- The five-year high for Change in Account Payables was $28.3 million in Q1 2025, with the low at -$9.0 million in Q4 2022.
- Average Change in Account Payables over 5 years is $1.9 million, with a median of $1.0 million recorded in 2024.
- The largest YoY upside for Change in Account Payables was 1409.44% in 2022 against a maximum downside of 1188.52% in 2022.
- Over 5 years, Change in Account Payables stood at -$9.0 million in 2022, then surged by 176.95% to $6.9 million in 2023, then jumped by 91.74% to $13.3 million in 2024, then sank by 94.34% to $753000.0 in 2025, then slumped by 849.93% to -$5.6 million in 2026.
- The last three Change in Account Payables figures came in at -$5.6 million (Q2 2026), -$2.9 million (Q1 2026), and $753000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | -6.74 Mn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | -53.00 Mn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | - |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | -5.65 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -109.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.65 Mn |
| Mar 31, 2026 | -2.94 Mn |
| Dec 31, 2025 | 753,000.00 |
| Sep 30, 2025 | -4.63 Mn |
| Jun 30, 2025 | 2.62 Mn |
| Mar 31, 2025 | 28.33 Mn |
| Dec 31, 2024 | 13.31 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 3.90 Mn |
| Mar 31, 2024 | -3.44 Mn |
| Dec 31, 2023 | 6.94 Mn |
| Sep 30, 2023 | 4.60 Mn |
| Jun 30, 2023 | -3.11 Mn |
| Mar 31, 2023 | -5.10 Mn |
| Dec 31, 2022 | -9.02 Mn |
| Sep 30, 2022 | -5.60 Mn |
| Jun 30, 2022 | 6.40 Mn |
| Mar 31, 2022 | 6.10 Mn |
| Dec 31, 2021 | 13.35 Mn |
| Sep 30, 2021 | 514,000.00 |